Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
7.38
+0.30 (4.24%)
Aug 29, 2025, 4:00 PM - Market closed
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $511.48 million as of August 29, 2025. Its market cap has decreased by -66.55% in one year.
Market Cap
511.48M
Enterprise Value
-202.77M
1-Year Change
-66.55%
Ranking
Category
Stock Price
$7.38
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $511.48M, an increase of 140.86%. That is a compound annual growth rate of 15.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 511.48M | -47.09% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | 382.42M | 126.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |